Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy Article Swipe
Jienchi Dorward
,
Yukteshwar Sookrajh
,
Richard Lessells
,
Elliot Bulo
,
Nicola Bodley
,
Lavanya Singh
,
Pravi Moodley
,
Natasha Samsunder
,
Paul K. Drain
,
Gail Hayward
,
Christopher Butler
,
Nigel Garrett
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1097/qai.0000000000003385
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1097/qai.0000000000003385
Supplemental Digital Content is Available in the Text.
Related Topics
Concepts
Dolutegravir
Efavirenz
Viremia
Virology
Antiretroviral drug
Medicine
Drug resistance
Antiretroviral therapy
Human immunodeficiency virus (HIV)
HIV drug resistance
Integrase inhibitor
Viral load
Biology
Genetics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1097/qai.0000000000003385
- OA Status
- hybrid
- Cited By
- 3
- References
- 10
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4392862498
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4392862498Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1097/qai.0000000000003385Digital Object Identifier
- Title
-
Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral TherapyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-03-11Full publication date if available
- Authors
-
Jienchi Dorward, Yukteshwar Sookrajh, Richard Lessells, Elliot Bulo, Nicola Bodley, Lavanya Singh, Pravi Moodley, Natasha Samsunder, Paul K. Drain, Gail Hayward, Christopher Butler, Nigel GarrettList of authors in order
- Landing page
-
https://doi.org/10.1097/qai.0000000000003385Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1097/qai.0000000000003385Direct OA link when available
- Concepts
-
Dolutegravir, Efavirenz, Viremia, Virology, Antiretroviral drug, Medicine, Drug resistance, Antiretroviral therapy, Human immunodeficiency virus (HIV), HIV drug resistance, Integrase inhibitor, Viral load, Biology, GeneticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2, 2024: 1Per-year citation counts (last 5 years)
- References (count)
-
10Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4392862498 |
|---|---|
| doi | https://doi.org/10.1097/qai.0000000000003385 |
| ids.doi | https://doi.org/10.1097/qai.0000000000003385 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38489494 |
| ids.openalex | https://openalex.org/W4392862498 |
| fwci | 3.11433599 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000188 |
| mesh[1].descriptor_ui | D014766 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | drug therapy |
| mesh[1].descriptor_name | Viremia |
| mesh[2].qualifier_ui | Q000188 |
| mesh[2].descriptor_ui | D015658 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | drug therapy |
| mesh[2].descriptor_name | HIV Infections |
| mesh[3].qualifier_ui | Q000627 |
| mesh[3].descriptor_ui | D010078 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | therapeutic use |
| mesh[3].descriptor_name | Oxazines |
| mesh[4].qualifier_ui | Q000627 |
| mesh[4].descriptor_ui | D048588 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | therapeutic use |
| mesh[4].descriptor_name | Benzoxazines |
| mesh[5].qualifier_ui | Q000627 |
| mesh[5].descriptor_ui | D044966 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | therapeutic use |
| mesh[5].descriptor_name | Anti-Retroviral Agents |
| mesh[6].qualifier_ui | Q000627 |
| mesh[6].descriptor_ui | D006575 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | therapeutic use |
| mesh[6].descriptor_name | Heterocyclic Compounds, 3-Ring |
| mesh[7].qualifier_ui | Q000627 |
| mesh[7].descriptor_ui | D011728 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | therapeutic use |
| mesh[7].descriptor_name | Pyridones |
| mesh[8].qualifier_ui | Q000627 |
| mesh[8].descriptor_ui | D019380 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | therapeutic use |
| mesh[8].descriptor_name | Anti-HIV Agents |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000480 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Alkynes |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D003521 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Cyclopropanes |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D010879 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Piperazines |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | Q000188 |
| mesh[13].descriptor_ui | D014766 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | drug therapy |
| mesh[13].descriptor_name | Viremia |
| mesh[14].qualifier_ui | Q000188 |
| mesh[14].descriptor_ui | D015658 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | drug therapy |
| mesh[14].descriptor_name | HIV Infections |
| mesh[15].qualifier_ui | Q000627 |
| mesh[15].descriptor_ui | D010078 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | therapeutic use |
| mesh[15].descriptor_name | Oxazines |
| mesh[16].qualifier_ui | Q000627 |
| mesh[16].descriptor_ui | D048588 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | therapeutic use |
| mesh[16].descriptor_name | Benzoxazines |
| mesh[17].qualifier_ui | Q000627 |
| mesh[17].descriptor_ui | D044966 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | therapeutic use |
| mesh[17].descriptor_name | Anti-Retroviral Agents |
| mesh[18].qualifier_ui | Q000627 |
| mesh[18].descriptor_ui | D006575 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | therapeutic use |
| mesh[18].descriptor_name | Heterocyclic Compounds, 3-Ring |
| mesh[19].qualifier_ui | Q000627 |
| mesh[19].descriptor_ui | D011728 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | therapeutic use |
| mesh[19].descriptor_name | Pyridones |
| mesh[20].qualifier_ui | Q000627 |
| mesh[20].descriptor_ui | D019380 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | therapeutic use |
| mesh[20].descriptor_name | Anti-HIV Agents |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D000480 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Alkynes |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D003521 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Cyclopropanes |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D010879 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Piperazines |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D006801 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Humans |
| mesh[25].qualifier_ui | Q000188 |
| mesh[25].descriptor_ui | D014766 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | drug therapy |
| mesh[25].descriptor_name | Viremia |
| mesh[26].qualifier_ui | Q000188 |
| mesh[26].descriptor_ui | D015658 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | drug therapy |
| mesh[26].descriptor_name | HIV Infections |
| mesh[27].qualifier_ui | Q000627 |
| mesh[27].descriptor_ui | D010078 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | therapeutic use |
| mesh[27].descriptor_name | Oxazines |
| mesh[28].qualifier_ui | Q000627 |
| mesh[28].descriptor_ui | D048588 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | therapeutic use |
| mesh[28].descriptor_name | Benzoxazines |
| mesh[29].qualifier_ui | Q000627 |
| mesh[29].descriptor_ui | D044966 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | therapeutic use |
| mesh[29].descriptor_name | Anti-Retroviral Agents |
| mesh[30].qualifier_ui | Q000627 |
| mesh[30].descriptor_ui | D006575 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | therapeutic use |
| mesh[30].descriptor_name | Heterocyclic Compounds, 3-Ring |
| mesh[31].qualifier_ui | Q000627 |
| mesh[31].descriptor_ui | D011728 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | therapeutic use |
| mesh[31].descriptor_name | Pyridones |
| mesh[32].qualifier_ui | Q000627 |
| mesh[32].descriptor_ui | D019380 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | therapeutic use |
| mesh[32].descriptor_name | Anti-HIV Agents |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D000480 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Alkynes |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D003521 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Cyclopropanes |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D010879 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Piperazines |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D006801 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Humans |
| mesh[37].qualifier_ui | Q000188 |
| mesh[37].descriptor_ui | D014766 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | drug therapy |
| mesh[37].descriptor_name | Viremia |
| mesh[38].qualifier_ui | Q000188 |
| mesh[38].descriptor_ui | D015658 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | drug therapy |
| mesh[38].descriptor_name | HIV Infections |
| mesh[39].qualifier_ui | Q000627 |
| mesh[39].descriptor_ui | D010078 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | therapeutic use |
| mesh[39].descriptor_name | Oxazines |
| mesh[40].qualifier_ui | Q000627 |
| mesh[40].descriptor_ui | D048588 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | therapeutic use |
| mesh[40].descriptor_name | Benzoxazines |
| mesh[41].qualifier_ui | Q000627 |
| mesh[41].descriptor_ui | D044966 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | therapeutic use |
| mesh[41].descriptor_name | Anti-Retroviral Agents |
| mesh[42].qualifier_ui | Q000627 |
| mesh[42].descriptor_ui | D006575 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | therapeutic use |
| mesh[42].descriptor_name | Heterocyclic Compounds, 3-Ring |
| mesh[43].qualifier_ui | Q000627 |
| mesh[43].descriptor_ui | D011728 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | therapeutic use |
| mesh[43].descriptor_name | Pyridones |
| mesh[44].qualifier_ui | Q000627 |
| mesh[44].descriptor_ui | D019380 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | therapeutic use |
| mesh[44].descriptor_name | Anti-HIV Agents |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D000480 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Alkynes |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D003521 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Cyclopropanes |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D010879 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Piperazines |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D006801 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Humans |
| mesh[49].qualifier_ui | Q000188 |
| mesh[49].descriptor_ui | D014766 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | drug therapy |
| mesh[49].descriptor_name | Viremia |
| type | article |
| title | Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy |
| biblio.issue | 5 |
| biblio.volume | 95 |
| biblio.last_page | e11 |
| biblio.first_page | e8 |
| grants[0].funder | https://openalex.org/F4320311904 |
| grants[0].award_id | 216421/Z/19/Z |
| grants[0].funder_display_name | Wellcome Trust |
| grants[1].funder | https://openalex.org/F4320316481 |
| grants[1].award_id | 0007365 |
| grants[1].funder_display_name | Global Challenges Research Fund |
| grants[2].funder | https://openalex.org/F4320319990 |
| grants[2].award_id | MIC-2016-018 |
| grants[2].funder_display_name | National Institute for Health and Care Research |
| topics[0].id | https://openalex.org/T10526 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | HIV/AIDS drug development and treatment |
| topics[1].id | https://openalex.org/T10082 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9995999932289124 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | HIV/AIDS Research and Interventions |
| topics[2].id | https://openalex.org/T10112 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9987000226974487 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2406 |
| topics[2].subfield.display_name | Virology |
| topics[2].display_name | HIV Research and Treatment |
| funders[0].id | https://openalex.org/F4320311904 |
| funders[0].ror | https://ror.org/029chgv08 |
| funders[0].display_name | Wellcome Trust |
| funders[1].id | https://openalex.org/F4320316481 |
| funders[1].ror | |
| funders[1].display_name | Global Challenges Research Fund |
| funders[2].id | https://openalex.org/F4320319990 |
| funders[2].ror | https://ror.org/0187kwz08 |
| funders[2].display_name | National Institute for Health and Care Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2779502633 |
| concepts[0].level | 5 |
| concepts[0].score | 0.9637804627418518 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q937224 |
| concepts[0].display_name | Dolutegravir |
| concepts[1].id | https://openalex.org/C2781432083 |
| concepts[1].level | 5 |
| concepts[1].score | 0.9226869344711304 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q422645 |
| concepts[1].display_name | Efavirenz |
| concepts[2].id | https://openalex.org/C2776185481 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7839118838310242 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1425304 |
| concepts[2].display_name | Viremia |
| concepts[3].id | https://openalex.org/C159047783 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6757104396820068 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[3].display_name | Virology |
| concepts[4].id | https://openalex.org/C3018457394 |
| concepts[4].level | 5 |
| concepts[4].score | 0.6523259878158569 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q583050 |
| concepts[4].display_name | Antiretroviral drug |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.6246764063835144 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C114851261 |
| concepts[6].level | 2 |
| concepts[6].score | 0.5855786800384521 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q12147416 |
| concepts[6].display_name | Drug resistance |
| concepts[7].id | https://openalex.org/C2993143319 |
| concepts[7].level | 4 |
| concepts[7].score | 0.5834298133850098 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q583050 |
| concepts[7].display_name | Antiretroviral therapy |
| concepts[8].id | https://openalex.org/C3013748606 |
| concepts[8].level | 2 |
| concepts[8].score | 0.5282701253890991 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q15787 |
| concepts[8].display_name | Human immunodeficiency virus (HIV) |
| concepts[9].id | https://openalex.org/C2778451633 |
| concepts[9].level | 5 |
| concepts[9].score | 0.5018088817596436 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q5629934 |
| concepts[9].display_name | HIV drug resistance |
| concepts[10].id | https://openalex.org/C2777302000 |
| concepts[10].level | 5 |
| concepts[10].score | 0.46770355105400085 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q412251 |
| concepts[10].display_name | Integrase inhibitor |
| concepts[11].id | https://openalex.org/C142462285 |
| concepts[11].level | 3 |
| concepts[11].score | 0.36120542883872986 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q2528140 |
| concepts[11].display_name | Viral load |
| concepts[12].id | https://openalex.org/C86803240 |
| concepts[12].level | 0 |
| concepts[12].score | 0.1799415647983551 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[12].display_name | Biology |
| concepts[13].id | https://openalex.org/C54355233 |
| concepts[13].level | 1 |
| concepts[13].score | 0.04523056745529175 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[13].display_name | Genetics |
| keywords[0].id | https://openalex.org/keywords/dolutegravir |
| keywords[0].score | 0.9637804627418518 |
| keywords[0].display_name | Dolutegravir |
| keywords[1].id | https://openalex.org/keywords/efavirenz |
| keywords[1].score | 0.9226869344711304 |
| keywords[1].display_name | Efavirenz |
| keywords[2].id | https://openalex.org/keywords/viremia |
| keywords[2].score | 0.7839118838310242 |
| keywords[2].display_name | Viremia |
| keywords[3].id | https://openalex.org/keywords/virology |
| keywords[3].score | 0.6757104396820068 |
| keywords[3].display_name | Virology |
| keywords[4].id | https://openalex.org/keywords/antiretroviral-drug |
| keywords[4].score | 0.6523259878158569 |
| keywords[4].display_name | Antiretroviral drug |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.6246764063835144 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/drug-resistance |
| keywords[6].score | 0.5855786800384521 |
| keywords[6].display_name | Drug resistance |
| keywords[7].id | https://openalex.org/keywords/antiretroviral-therapy |
| keywords[7].score | 0.5834298133850098 |
| keywords[7].display_name | Antiretroviral therapy |
| keywords[8].id | https://openalex.org/keywords/human-immunodeficiency-virus |
| keywords[8].score | 0.5282701253890991 |
| keywords[8].display_name | Human immunodeficiency virus (HIV) |
| keywords[9].id | https://openalex.org/keywords/hiv-drug-resistance |
| keywords[9].score | 0.5018088817596436 |
| keywords[9].display_name | HIV drug resistance |
| keywords[10].id | https://openalex.org/keywords/integrase-inhibitor |
| keywords[10].score | 0.46770355105400085 |
| keywords[10].display_name | Integrase inhibitor |
| keywords[11].id | https://openalex.org/keywords/viral-load |
| keywords[11].score | 0.36120542883872986 |
| keywords[11].display_name | Viral load |
| keywords[12].id | https://openalex.org/keywords/biology |
| keywords[12].score | 0.1799415647983551 |
| keywords[12].display_name | Biology |
| keywords[13].id | https://openalex.org/keywords/genetics |
| keywords[13].score | 0.04523056745529175 |
| keywords[13].display_name | Genetics |
| language | en |
| locations[0].id | doi:10.1097/qai.0000000000003385 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S157460402 |
| locations[0].source.issn | 1525-4135, 1944-7884 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1525-4135 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| locations[0].source.host_organization | https://openalex.org/P4310315671 |
| locations[0].source.host_organization_name | Lippincott Williams & Wilkins |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315671 |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| locations[0].landing_page_url | https://doi.org/10.1097/qai.0000000000003385 |
| locations[1].id | pmid:38489494 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of acquired immune deficiency syndromes (1999) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38489494 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10927299 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10927299/pdf/qai-95-e8.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Acquir Immune Defic Syndr |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10927299 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5081748396 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6072-1430 |
| authorships[0].author.display_name | Jienchi Dorward |
| authorships[0].countries | GB, ZA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I40120149 |
| authorships[0].affiliations[0].raw_affiliation_string | Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom; |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I2800715850, https://openalex.org/I95023434 |
| authorships[0].affiliations[1].raw_affiliation_string | Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa; |
| authorships[0].institutions[0].id | https://openalex.org/I40120149 |
| authorships[0].institutions[0].ror | https://ror.org/052gg0110 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I40120149 |
| authorships[0].institutions[0].country_code | GB |
| authorships[0].institutions[0].display_name | University of Oxford |
| authorships[0].institutions[1].id | https://openalex.org/I2800715850 |
| authorships[0].institutions[1].ror | https://ror.org/04qkg4668 |
| authorships[0].institutions[1].type | other |
| authorships[0].institutions[1].lineage | https://openalex.org/I2800715850 |
| authorships[0].institutions[1].country_code | ZA |
| authorships[0].institutions[1].display_name | Centre for the AIDS Programme of Research in South Africa |
| authorships[0].institutions[2].id | https://openalex.org/I95023434 |
| authorships[0].institutions[2].ror | https://ror.org/04qzfn040 |
| authorships[0].institutions[2].type | education |
| authorships[0].institutions[2].lineage | https://openalex.org/I95023434 |
| authorships[0].institutions[2].country_code | ZA |
| authorships[0].institutions[2].display_name | University of KwaZulu-Natal |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jienchi Dorward |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa;, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom; |
| authorships[1].author.id | https://openalex.org/A5006424587 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-9029-5153 |
| authorships[1].author.display_name | Yukteshwar Sookrajh |
| authorships[1].countries | ZA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2803062987 |
| authorships[1].affiliations[0].raw_affiliation_string | eThekwini Municipality Health Unit, Durban, South Africa; |
| authorships[1].institutions[0].id | https://openalex.org/I2803062987 |
| authorships[1].institutions[0].ror | https://ror.org/01g1ykj19 |
| authorships[1].institutions[0].type | government |
| authorships[1].institutions[0].lineage | https://openalex.org/I2803062987 |
| authorships[1].institutions[0].country_code | ZA |
| authorships[1].institutions[0].display_name | eThekwini Municipality |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Yukteshwar Sookrajh |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | eThekwini Municipality Health Unit, Durban, South Africa; |
| authorships[2].author.id | https://openalex.org/A5062343676 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-0926-710X |
| authorships[2].author.display_name | Richard Lessells |
| authorships[2].countries | ZA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I95023434 |
| authorships[2].affiliations[0].raw_affiliation_string | KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa; |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I2800715850, https://openalex.org/I95023434 |
| authorships[2].affiliations[1].raw_affiliation_string | Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa; |
| authorships[2].institutions[0].id | https://openalex.org/I2800715850 |
| authorships[2].institutions[0].ror | https://ror.org/04qkg4668 |
| authorships[2].institutions[0].type | other |
| authorships[2].institutions[0].lineage | https://openalex.org/I2800715850 |
| authorships[2].institutions[0].country_code | ZA |
| authorships[2].institutions[0].display_name | Centre for the AIDS Programme of Research in South Africa |
| authorships[2].institutions[1].id | https://openalex.org/I95023434 |
| authorships[2].institutions[1].ror | https://ror.org/04qzfn040 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I95023434 |
| authorships[2].institutions[1].country_code | ZA |
| authorships[2].institutions[1].display_name | University of KwaZulu-Natal |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Richard Lessells |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa;, KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa; |
| authorships[3].author.id | https://openalex.org/A5069372778 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Elliot Bulo |
| authorships[3].countries | ZA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2803062987 |
| authorships[3].affiliations[0].raw_affiliation_string | eThekwini Municipality Health Unit, Durban, South Africa; |
| authorships[3].institutions[0].id | https://openalex.org/I2803062987 |
| authorships[3].institutions[0].ror | https://ror.org/01g1ykj19 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I2803062987 |
| authorships[3].institutions[0].country_code | ZA |
| authorships[3].institutions[0].display_name | eThekwini Municipality |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Elliot Bulo |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | eThekwini Municipality Health Unit, Durban, South Africa; |
| authorships[4].author.id | https://openalex.org/A5087074769 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Nicola Bodley |
| authorships[4].countries | ZA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I2800715850, https://openalex.org/I95023434 |
| authorships[4].affiliations[0].raw_affiliation_string | Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa; |
| authorships[4].institutions[0].id | https://openalex.org/I2800715850 |
| authorships[4].institutions[0].ror | https://ror.org/04qkg4668 |
| authorships[4].institutions[0].type | other |
| authorships[4].institutions[0].lineage | https://openalex.org/I2800715850 |
| authorships[4].institutions[0].country_code | ZA |
| authorships[4].institutions[0].display_name | Centre for the AIDS Programme of Research in South Africa |
| authorships[4].institutions[1].id | https://openalex.org/I95023434 |
| authorships[4].institutions[1].ror | https://ror.org/04qzfn040 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I95023434 |
| authorships[4].institutions[1].country_code | ZA |
| authorships[4].institutions[1].display_name | University of KwaZulu-Natal |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Nicola Bodley |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa; |
| authorships[5].author.id | https://openalex.org/A5051396765 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-1726-4454 |
| authorships[5].author.display_name | Lavanya Singh |
| authorships[5].countries | ZA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I95023434 |
| authorships[5].affiliations[0].raw_affiliation_string | KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa; |
| authorships[5].institutions[0].id | https://openalex.org/I95023434 |
| authorships[5].institutions[0].ror | https://ror.org/04qzfn040 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I95023434 |
| authorships[5].institutions[0].country_code | ZA |
| authorships[5].institutions[0].display_name | University of KwaZulu-Natal |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Lavanya Singh |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa; |
| authorships[6].author.id | https://openalex.org/A5030189452 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9946-8783 |
| authorships[6].author.display_name | Pravi Moodley |
| authorships[6].countries | ZA |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I107920810, https://openalex.org/I95023434 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Virology, University of KwaZulu-Natal and National Health Laboratory Service, Inkosi Albert Luthuli Central Hospital, KwaZulu-Natal, South Africa; |
| authorships[6].institutions[0].id | https://openalex.org/I107920810 |
| authorships[6].institutions[0].ror | https://ror.org/00znvbk37 |
| authorships[6].institutions[0].type | government |
| authorships[6].institutions[0].lineage | https://openalex.org/I107920810 |
| authorships[6].institutions[0].country_code | ZA |
| authorships[6].institutions[0].display_name | National Health Laboratory Service |
| authorships[6].institutions[1].id | https://openalex.org/I95023434 |
| authorships[6].institutions[1].ror | https://ror.org/04qzfn040 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I95023434 |
| authorships[6].institutions[1].country_code | ZA |
| authorships[6].institutions[1].display_name | University of KwaZulu-Natal |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Pravikrishnen Moodley |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Virology, University of KwaZulu-Natal and National Health Laboratory Service, Inkosi Albert Luthuli Central Hospital, KwaZulu-Natal, South Africa; |
| authorships[7].author.id | https://openalex.org/A5023679271 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-3582-5718 |
| authorships[7].author.display_name | Natasha Samsunder |
| authorships[7].countries | ZA |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I2800715850, https://openalex.org/I95023434 |
| authorships[7].affiliations[0].raw_affiliation_string | Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa; |
| authorships[7].institutions[0].id | https://openalex.org/I2800715850 |
| authorships[7].institutions[0].ror | https://ror.org/04qkg4668 |
| authorships[7].institutions[0].type | other |
| authorships[7].institutions[0].lineage | https://openalex.org/I2800715850 |
| authorships[7].institutions[0].country_code | ZA |
| authorships[7].institutions[0].display_name | Centre for the AIDS Programme of Research in South Africa |
| authorships[7].institutions[1].id | https://openalex.org/I95023434 |
| authorships[7].institutions[1].ror | https://ror.org/04qzfn040 |
| authorships[7].institutions[1].type | education |
| authorships[7].institutions[1].lineage | https://openalex.org/I95023434 |
| authorships[7].institutions[1].country_code | ZA |
| authorships[7].institutions[1].display_name | University of KwaZulu-Natal |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Natasha Samsunder |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa; |
| authorships[8].author.id | https://openalex.org/A5023486394 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-3300-3817 |
| authorships[8].author.display_name | Paul K. Drain |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I201448701 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA; and |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I201448701 |
| authorships[8].affiliations[1].raw_affiliation_string | Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, WA; |
| authorships[8].affiliations[2].institution_ids | https://openalex.org/I201448701 |
| authorships[8].affiliations[2].raw_affiliation_string | Department of Medicine, School of Medicine, University of Washington, Seattle, WA; |
| authorships[8].institutions[0].id | https://openalex.org/I201448701 |
| authorships[8].institutions[0].ror | https://ror.org/00cvxb145 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I201448701 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | University of Washington |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Paul K. Drain |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA; and, Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, WA;, Department of Medicine, School of Medicine, University of Washington, Seattle, WA; |
| authorships[9].author.id | https://openalex.org/A5023574292 |
| authorships[9].author.orcid | https://orcid.org/0000-0003-0852-627X |
| authorships[9].author.display_name | Gail Hayward |
| authorships[9].countries | GB |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I40120149 |
| authorships[9].affiliations[0].raw_affiliation_string | Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom; |
| authorships[9].institutions[0].id | https://openalex.org/I40120149 |
| authorships[9].institutions[0].ror | https://ror.org/052gg0110 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I40120149 |
| authorships[9].institutions[0].country_code | GB |
| authorships[9].institutions[0].display_name | University of Oxford |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Gail Hayward |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom; |
| authorships[10].author.id | https://openalex.org/A5079149152 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-0102-3453 |
| authorships[10].author.display_name | Christopher Butler |
| authorships[10].countries | GB |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I40120149 |
| authorships[10].affiliations[0].raw_affiliation_string | Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom; |
| authorships[10].institutions[0].id | https://openalex.org/I40120149 |
| authorships[10].institutions[0].ror | https://ror.org/052gg0110 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I40120149 |
| authorships[10].institutions[0].country_code | GB |
| authorships[10].institutions[0].display_name | University of Oxford |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Christopher C. Butler |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom; |
| authorships[11].author.id | https://openalex.org/A5007528258 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-4530-234X |
| authorships[11].author.display_name | Nigel Garrett |
| authorships[11].countries | ZA |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I2800715850, https://openalex.org/I95023434 |
| authorships[11].affiliations[0].raw_affiliation_string | Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa; |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I95023434 |
| authorships[11].affiliations[1].raw_affiliation_string | Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa. |
| authorships[11].institutions[0].id | https://openalex.org/I2800715850 |
| authorships[11].institutions[0].ror | https://ror.org/04qkg4668 |
| authorships[11].institutions[0].type | other |
| authorships[11].institutions[0].lineage | https://openalex.org/I2800715850 |
| authorships[11].institutions[0].country_code | ZA |
| authorships[11].institutions[0].display_name | Centre for the AIDS Programme of Research in South Africa |
| authorships[11].institutions[1].id | https://openalex.org/I95023434 |
| authorships[11].institutions[1].ror | https://ror.org/04qzfn040 |
| authorships[11].institutions[1].type | education |
| authorships[11].institutions[1].lineage | https://openalex.org/I95023434 |
| authorships[11].institutions[1].country_code | ZA |
| authorships[11].institutions[1].display_name | University of KwaZulu-Natal |
| authorships[11].author_position | last |
| authorships[11].raw_author_name | Nigel Garrett |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu–Natal, Durban, South Africa;, Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1097/qai.0000000000003385 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10526 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | HIV/AIDS drug development and treatment |
| related_works | https://openalex.org/W3043102130, https://openalex.org/W4380627575, https://openalex.org/W3043161048, https://openalex.org/W4320475007, https://openalex.org/W3132844936, https://openalex.org/W4366290175, https://openalex.org/W3089405003, https://openalex.org/W4381377183, https://openalex.org/W4306795632, https://openalex.org/W4390903428 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1097/qai.0000000000003385 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S157460402 |
| best_oa_location.source.issn | 1525-4135, 1944-7884 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1525-4135 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| best_oa_location.source.host_organization | https://openalex.org/P4310315671 |
| best_oa_location.source.host_organization_name | Lippincott Williams & Wilkins |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315671 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| best_oa_location.landing_page_url | https://doi.org/10.1097/qai.0000000000003385 |
| primary_location.id | doi:10.1097/qai.0000000000003385 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S157460402 |
| primary_location.source.issn | 1525-4135, 1944-7884 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1525-4135 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| primary_location.source.host_organization | https://openalex.org/P4310315671 |
| primary_location.source.host_organization_name | Lippincott Williams & Wilkins |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315671 |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| primary_location.landing_page_url | https://doi.org/10.1097/qai.0000000000003385 |
| publication_date | 2024-03-11 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2807026831, https://openalex.org/W2800677865, https://openalex.org/W3093018885, https://openalex.org/W2889612530, https://openalex.org/W2462213043, https://openalex.org/W2743051020, https://openalex.org/W3132866764, https://openalex.org/W4366976902, https://openalex.org/W2990676722, https://openalex.org/W3128867251 |
| referenced_works_count | 10 |
| abstract_inverted_index.in | 5 |
| abstract_inverted_index.is | 3 |
| abstract_inverted_index.the | 6 |
| abstract_inverted_index.Text. | 7 |
| abstract_inverted_index.Content | 2 |
| abstract_inverted_index.Digital | 1 |
| abstract_inverted_index.Available | 4 |
| abstract_inverted_index.Supplemental | 0 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 90 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 12 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8299999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.80970337 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |